CAS 17316-67-5

P-[1-(Butylamino)-1-methylethyl]phosphinic acid

Description:

P-[1-(Butylamino)-1-methylethyl]phosphinic acid, with the CAS number 17316-67-5, is a phosphinic acid derivative characterized by the presence of a phosphinic functional group (-P(=O)(OH)R) where R is a butylamino group attached to a branched alkyl chain. This compound typically exhibits properties associated with phosphinic acids, such as being a weak acid and having potential applications in agriculture as a herbicide or plant growth regulator. Its structure suggests it may interact with biological systems, potentially influencing metabolic pathways or enzyme activities. The butylamino substituent can enhance its solubility in organic solvents and may affect its biological activity. Additionally, the presence of the phosphinic acid moiety indicates that it may participate in various chemical reactions, including nucleophilic substitutions and coordination with metal ions. Safety and handling precautions should be observed, as with many chemical substances, due to potential toxicity or environmental impact. Overall, this compound's unique structure and functional groups contribute to its potential utility in various chemical and agricultural applications.

Formula: C₇H₁₈NO₂P

InChI: InChI=1/C7H16NO2P/c1-4-5-6-8-7(2,3)11(9)10/h8H,4-6H2,1-3H3/p+1

InChI key: InChIKey=WCXWARPXYQCRPP-UHFFFAOYSA-N

SMILES: C(NCCCC)(P(=O)O)(C)C

Synonyms:

• (1-Butylamino-1-methyl-ethyl)-phosphinic acid
• 1-(Butylamino)-1-methylethylphosphonous acid
• Butaphosphan
• P-[1-(Butylamino)-1-methylethyl]phosphinic acid
• Phosphinic acid, P-[1-(butylamino)-1-methylethyl]-
• Phosphinic acid, [1-(butylamino)-1-methylethyl]-
• [1-(Butylamino)-1-Methylethyl](Hydroxy)Oxophosphonium
• [2-(Butylamino)propan-2-yl]phosphinic acid
• [1-Butylamino-1-methylethyl]phosphinic acid
• BUTAFOSFAN
• BUTAPHOSPHAN(BUTAFOSFAN)

Butafosfan

CAS: 17316-67-5

Color and Shape: Neat

Ref: 61-FOR3311.00

1-(Butylamino)-1-methylethylphosphonous acid

CAS: 17316-67-5

Formula: C₇H₁₈NO₂P

Purity: 99%

Color and Shape: Solid

Molecular weight: 179.1971

Ref: IN-DA001YOU

Butafosfan

CAS: 17316-67-5

Formula: C₇H₁₈NO₂P

Purity: ≥ 98.0%

Color and Shape: White to almost white powder

Molecular weight: 179.79

Ref: 7W-GX4252

Butafosfan

CAS: 17316-67-5

Formula: C₇H₁₈NO₂P

Color and Shape: White To Off-White Solid

Molecular weight: 179.20

Ref: 4Z-B-143001

Butafosfan

CAS: 17316-67-5

Butafosfan, often with cyanocobalamin, boosts lipid metabolism in livestock to prevent/treat deficiencies and ketosis.

Formula: C₇H₁₈NO₂P

Color and Shape: Solid

Molecular weight: 179.2

Ref: TM-T37849

Butafosfan

CAS: 17316-67-5

Formula: C₇H₁₈NO₂P

Color and Shape: Neat

Molecular weight: 179.20

Ref: 86-MM3311.00

[1-(Butylamino)-1-methyl-ethyl]phosphinic acid

CAS: 17316-67-5

[1-(Butylamino)-1-methyl-ethyl]phosphinic acid

Purity: 98%

Molecular weight: 179.20g/mol

Ref: 54-OR907240

Butafosfan

Controlled Product

CAS: 17316-67-5

Stability Hygroscopic
Applications Butafosfan, a component of Catosal, is licensed for the treatment of metabolic disorders or as a tonic in swine. It reduces the stress-induced cortisol (C696302, d4 labelled) response after mixing of unfamiliar pigs. It can also increase milk production in Holstein cows in combination with cyanocobalamin.
References De Groot, J., et al.: J. Vet. Pharmacol. Ther., 26, 222 (2003); Pereira, R., et al.: Animal, 7, 1143 (2013)

Formula: C₇H₁₈NO₂P

Color and Shape: White To Off-White

Molecular weight: 179.20

Ref: TR-B689410

Butaphosphan

CAS: 17316-67-5

Butaphosphan is a drug that has been shown to have clinical relevance for the treatment of metabolic disorders. It is a prodrug that is converted into butaprost-diol, which has been shown to improve insulin sensitivity and reduce aminotransferase activity in rats. Butaphosphan can be used as an alternative to aminotransferase inhibitors such as ursodeoxycholic acid and cholestyramine for the treatment of patients with primary biliary cirrhosis. This drug has also been shown to have a protective effect on fatty acid metabolism, which may be due to its ability to inhibit the activity of enzymes involved in fatty acid synthesis. Butaphosphan is metabolized by cytochrome P450 enzymes and hydroxylases and can be detected using LC-MS/MS methods. The drug has also been shown to have beneficial effects on cortisol concentrations and liver histology when administered orally.

Formula: C₇H₁₈NO₂P

Purity: Min. 95%

Color and Shape: White Powder

Molecular weight: 179.2 g/mol

Ref: 3D-FB31891